Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy
Clinical trial NCT04554680 · UNKNOWN
Trial details
- NCT number
- NCT04554680
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2021-12-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.